CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities
Net loss	$ (4,270,088)	$ (696,880)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expense	1,702	132
Stock-based compensation	272,680
Loss on the issuance of Preferred Stock Units	3,124,285
Change in fair value of Series A Warrants	(786,397)
Change in fair value of derivative liability	(224,065)
Changes in operating assets and liabilities:
Prepaid fee to related party	(25,000)	(25,000)
Prepaid expenses and other current assets	13,647	(57,089)
Accounts payable	(15,205)	190,389
Accrued expenses and other current liabilities	83,334	69,760
Net cash flows used in operating activities	(1,825,107)	(518,688)
Cash flows from investing activities
Purchase of equipment	(5,301)	(12,528)
Net cash flows used in investing activities	(5,301)	(12,528)
Cash flows from financing activities
Proceeds from issuance of Preferred Stock Units	2,537,012
Payment of offering costs	(388,628)
Proceeds from common stock issued upon exercise of warrants	2,000
Net cash flows provided by financing activities	2,150,384
Net increase (decrease) in cash	319,976	(531,216)
Cash, beginning of period	585,680	767,268
Cash, end of period	905,656	$ 236,052
Supplemental non-cash financing activities
Fair value of Series A Warrants on issuance dates (aggregate)	4,050,706
Fair value of derivative liability on issuance dates (aggregate)	$ 1,221,963